Skip to main content
生物谷 logo

生物谷 — Investor Relations & Filings

Ticker · 920266 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 570 across all filing types
Latest filing 2022-01-09 Board/Management Inform…
Country CN China
Listing Beijing Stock Exchange 920266

About 生物谷

https://www.bioon.com/

Bio-Valley specializes in the research, development, and manufacturing of botanical-based therapeutic solutions, with a primary focus on cardiovascular and cerebrovascular health. The company is a leader in the industrialization of Erigeron breviscapus (Dengzhanhua), a botanical resource used for treating ischemic stroke and its sequelae. Its core product portfolio includes Dengzhan Shengmai Capsules and Dengzhan Xixin Injection, which are utilized in clinical settings for their neuroprotective and microcirculation-improving properties. Bio-Valley maintains a comprehensive value chain encompassing botanical cultivation, standardized extraction, and large-scale production. By leveraging advanced extraction technologies and rigorous quality control, the company provides evidence-based solutions for chronic disease management and geriatric care.

Recent filings

Filing Released Lang Actions
第四监事会第一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolution from the first meeting of the fourth supervisory board of the company. It details the meeting date, attendance, agenda, and voting results related to the election of the supervisory board chairman. There is no financial data, no mention of annual or quarterly reports, no audit information, and no investor presentation content. The document is an official announcement of board/management changes, specifically related to the supervisory board leadership. It is not a full report but a governance-related announcement. Therefore, the appropriate classification is Board/Management Information (MANG). The document length is short and focused on governance matters, not a report publication or regulatory filing fallback.
2022-01-09 Chinese
职工监事换届公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the change in the company's employee representative supervisor (职工监事换届公告). It details the election of a new employee representative supervisor, the compliance with legal and governance requirements, and the impact of this change on the company. There is no financial data, no mention of financial results, no report attached or referenced, and no indication of a meeting or voting results beyond the election of a supervisor. This fits the category of Board/Management Information (MANG), as it concerns changes in company supervisory personnel, which is part of senior management or board-related announcements.
2021-12-16 Chinese
2021年第二次临时股东大会决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2021 second extraordinary shareholders' meeting of Yunnan Shengwu Gu Pharmaceutical Co., Ltd. It includes information about the meeting's convening, attendance, voting results on board and supervisory board nominations, and legal opinions confirming the meeting's compliance with laws and regulations. The content focuses on changes in the company's board of directors and supervisory board members, including their appointment and term details. There are no financial statements or performance data, so it is not an annual or interim report. It is not a proxy solicitation or voting results announcement alone, but a formal announcement of board and management changes. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length (4793 characters) and detailed content support this classification with high confidence.
2021-12-16 Chinese
2021年第一次职工代表大会决议公告
Regulatory Filings Classification · 90% confidence The document is a resolution announcement from a company's employee representative meeting, detailing the election of a supervisory board member. It includes meeting attendance, voting results, and compliance with company law and articles of association. There is no financial data, no mention of annual or quarterly reports, no audit information, no earnings data, and no regulatory filings or certifications. The content is about internal governance and election results within the company, but it is not a general board or management change announcement (which usually involves directors or senior management changes). It is also not a proxy solicitation or voting results announcement for shareholders, but rather a resolution from an employee representative meeting. Given the nature of the document, it best fits under Regulatory Filings (RNS) as a general announcement that does not fit other categories.
2021-12-16 Chinese
持股百分之五以上股东减持股份结果公告
Major Shareholding Notification Classification · 100% confidence The document is a formal announcement regarding the reduction of shareholdings by shareholders holding more than 5% of the company's shares. It details the shareholders' identities, the number and percentage of shares held before and after the reduction, the methods and periods of share reduction, and confirms that the reduction plan was completed as disclosed. This type of document is a notification about changes in major shareholdings, specifically a reduction in significant share ownership levels. It does not contain financial statements, management discussion, or other report content. Therefore, it fits the category of Major Shareholding Notification (MRQ). The document length is short and focused solely on shareholding changes, confirming the classification.
2021-12-08 Chinese
第三届监事会第十五次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolution passed at the 15th meeting of the third Supervisory Board of Yunnan Biological Valley Pharmaceutical Co., Ltd. It details the meeting date, attendance, agenda, and voting results regarding the nomination of candidates for the fourth Supervisory Board. It references compliance with company law and regulations and mentions that the resolution will be submitted to the shareholders' meeting for approval. The document is a corporate governance announcement about board member nominations and meeting resolutions, not a full report, financial statement, or regulatory filing. It fits best under Board/Management Information (MANG) as it concerns changes in the supervisory board members and related governance matters. The document length is short and focused on board resolutions, not an AGM presentation or voting results announcement. Therefore, the classification is MANG with high confidence.
2021-11-29 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.